Thomas Butler loses appeal

Jailed plague researcher to be freed in January, colleagues discuss how to help him work again

Written byJohn Dudley Miller
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

A federal appeals court yesterday upheld the conviction and prison sentence of former Texas Tech professor Thomas Butler for illegally shipping plague samples and for defrauding the university in unrelated consulting for drug companies. Yesterday, a National Academy of Sciences (NAS) committee also met to discuss how to help him find a suitable job upon his release, scheduled for January.

In a unanimous decision, three judges from the US Court of Appeals for the Fifth Circuit in New Orleans—temporarily operating out of Houston—rejected Butler's claim that six errors in his original trial prejudiced the jury against him. In their unsigned opinion, the judges concluded "that the district court did not commit reversible error." Butler has already served over 18 months of the 24-month sentence he received in March 2004.

Not surprisingly, scientists who have supported Butler decried the decision. "I'm bitterly disappointed but still confident in the American judicial system. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform